
Amanda C. Walke
Examiner (ID: 15144, Phone: (571)272-1337 , Office: P/1722 )
| Most Active Art Unit | 1722 |
| Art Unit(s) | 1722, 1737, 1752, 1795 |
| Total Applications | 2746 |
| Issued Applications | 2313 |
| Pending Applications | 137 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20412535
[patent_doc_number] => 12495793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Preservation of stem cells
[patent_app_type] => utility
[patent_app_number] => 17/425383
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 0
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425383
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/425383 | Preservation of stem cells | Jan 22, 2020 | Issued |
Array
(
[id] => 17505450
[patent_doc_number] => 20220098552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHOD FOR THE IN VITRO OR EX VIVO AMPLIFICATION OF HUMAN ADIPOSE TISSUE STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/421840
[patent_app_country] => US
[patent_app_date] => 2020-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421840
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421840 | METHOD FOR THE IN VITRO OR EX VIVO AMPLIFICATION OF HUMAN ADIPOSE TISSUE STEM CELLS | Jan 12, 2020 | Pending |
Array
(
[id] => 17299999
[patent_doc_number] => 20210395838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => COMPOSITIONS AND METHODS RELATED TO REPORTER SYSTEMS AND LARGE ANIMAL MODELS FOR EVALUATING GENE EDITING TECHNOLOGY
[patent_app_type] => utility
[patent_app_number] => 17/421279
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421279 | COMPOSITIONS AND METHODS RELATED TO REPORTER SYSTEMS AND LARGE ANIMAL MODELS FOR EVALUATING GENE EDITING TECHNOLOGY | Jan 9, 2020 | Abandoned |
Array
(
[id] => 17503439
[patent_doc_number] => 20220096541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHODS TO TREAT MITOCHONDRIAL-ASSOCIATED DYSFUNCTIONS OR DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/421909
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421909 | METHODS TO TREAT MITOCHONDRIAL-ASSOCIATED DYSFUNCTIONS OR DISEASES | Jan 9, 2020 | Pending |
Array
(
[id] => 17398242
[patent_doc_number] => 20220040332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => GENE THERAPY FOR TREATING FAMILIAL HYPERCHOLESTEROLEMIA
[patent_app_type] => utility
[patent_app_number] => 17/414263
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414263
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414263 | GENE THERAPY FOR TREATING FAMILIAL HYPERCHOLESTEROLEMIA | Dec 18, 2019 | Abandoned |
Array
(
[id] => 18005299
[patent_doc_number] => 20220364065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => COMPOSITION FOR REMOVING PLURIPOTENT STEM CELLS AND METHOD OF REMOVING PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/414511
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414511
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414511 | COMPOSITION FOR REMOVING PLURIPOTENT STEM CELLS AND METHOD OF REMOVING PLURIPOTENT STEM CELLS | Dec 18, 2019 | Abandoned |
Array
(
[id] => 17480718
[patent_doc_number] => 20220088222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/414425
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414425 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES | Dec 17, 2019 | Pending |
Array
(
[id] => 17334697
[patent_doc_number] => 20220001028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => AAV VIRAL VECTORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/309403
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309403 | AAV VIRAL VECTORS AND USES THEREOF | Nov 26, 2019 | Pending |
Array
(
[id] => 17357123
[patent_doc_number] => 20220017919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => RECOMBINANT VECTORS SUITABLE FOR THE TREATMENT OF IPEX SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/295093
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295093
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295093 | RECOMBINANT VECTORS SUITABLE FOR THE TREATMENT OF IPEX SYNDROME | Nov 18, 2019 | Pending |
Array
(
[id] => 17297862
[patent_doc_number] => 20210393701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => REGENERATIVE ABSCOPAL EFFECTS
[patent_app_type] => utility
[patent_app_number] => 17/309207
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -82
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309207 | REGENERATIVE ABSCOPAL EFFECTS | Nov 7, 2019 | Pending |
Array
(
[id] => 17274744
[patent_doc_number] => 20210380942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/288376
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/288376 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES | Oct 23, 2019 | Abandoned |
Array
(
[id] => 17274738
[patent_doc_number] => 20210380936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => An Implantable Construct, Methods of Manufacturing, and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/288140
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288140
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/288140 | An Implantable Construct, Methods of Manufacturing, and Uses Thereof | Oct 22, 2019 | Abandoned |
Array
(
[id] => 17342019
[patent_doc_number] => 20220008350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => PROCESS FOR ENGINEERING TARGETED NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/309030
[patent_app_country] => US
[patent_app_date] => 2019-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309030
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309030 | PROCESS FOR ENGINEERING TARGETED NANOPARTICLES | Oct 15, 2019 | Pending |
Array
(
[id] => 17258843
[patent_doc_number] => 20210371828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => INDUCED PLURIPOTENT CELL COMPRISING A CONTROLLABLE TRANSGENE FOR CONDITIONAL IMMORTALIZATION
[patent_app_type] => utility
[patent_app_number] => 17/284428
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284428 | INDUCED PLURIPOTENT CELL COMPRISING A CONTROLLABLE TRANSGENE FOR CONDITIONAL IMMORTALIZATION | Oct 10, 2019 | Pending |
Array
(
[id] => 17314826
[patent_doc_number] => 20210403874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => Method for Producing Stem/Precursor Cells, By Using Low Molecular Weight Compound, From Cells Derived From Endodermal Tissue or Organ
[patent_app_type] => utility
[patent_app_number] => 17/285038
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285038 | Method for Producing Stem/Precursor Cells, By Using Low Molecular Weight Compound, From Cells Derived From Endodermal Tissue or Organ | Oct 10, 2019 | Pending |
Array
(
[id] => 17214857
[patent_doc_number] => 20210348194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => ENGINEERED NUCLEIC ACID CONSTRUCTS ENCODING AAV PRODUCTION PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/282878
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -136
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282878 | ENGINEERED NUCLEIC ACID CONSTRUCTS ENCODING AAV PRODUCTION PROTEINS | Oct 3, 2019 | Abandoned |
Array
(
[id] => 17198643
[patent_doc_number] => 20210338737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => TISSUE REPAIR BY ACTIVATED CELLS
[patent_app_type] => utility
[patent_app_number] => 17/273461
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273461 | TISSUE REPAIR BY ACTIVATED CELLS | Aug 28, 2019 | Pending |
Array
(
[id] => 17428706
[patent_doc_number] => 20220056414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => METHOD FOR PRODUCING A VIRUS-FREE PLATELET LYSATE MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/279305
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279305
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/279305 | METHOD FOR PRODUCING A VIRUS-FREE PLATELET LYSATE MATERIAL | Aug 22, 2019 | Pending |
Array
(
[id] => 20453243
[patent_doc_number] => 12516295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Generation of pancreatic progenitor cells and beta cells from human pluripotent stem cells
[patent_app_type] => utility
[patent_app_number] => 17/269233
[patent_app_country] => US
[patent_app_date] => 2019-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 4
[patent_no_of_words] => 3728
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269233 | Generation of pancreatic progenitor cells and beta cells from human pluripotent stem cells | Aug 21, 2019 | Issued |
Array
(
[id] => 16932740
[patent_doc_number] => 20210198629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASING BEIGING OF WHITE ADIPOSE TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/269964
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269964
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269964 | COMPOSITIONS AND METHODS FOR INCREASING BEIGING OF WHITE ADIPOSE TISSUE | Aug 19, 2019 | Abandoned |